β-Blockers Seem Not to Reduce Risks More Than One Year After Heart Attack
WEDNESDAY, May 3, 2023 (HealthDay News) -- For patients with myocardial infarction (MI), beta-blocker (βB) treatment beyond one year after MI does not appear to reduce the risk for mortality or further MI, according to a study published online May 2 in Heart.
Divan Ishak, M.D., from Uppsala University in Sweden, and colleagues conducted a nationwide cohort study involving 43,618 patients with MI between 2005 and 2016. Follow-up began one year after hospitalization (index date). Patients were categorized into two groups according to βB treatment; 78.5 and 21.5 percent of patients received βB treatment and did not receive βB treatment, respectively, at the index date.
The researchers found that the unadjusted rate of primary outcome (composite of all-cause mortality, MI, unscheduled revascularization, and hospitalization for heart failure) was lower among those who received versus those who did not receive βB treatment (3.8 versus 4.9 events per 100 person years; hazard ratio, 0.76; 95 percent confidence interval, 0.73 to 1.04). The risk for the primary outcome was not different according to βB treatment after inverse propensity score weighting and multivariable adjustment (hazard ratio, 0.99; 95 percent confidence interval, 0.93 to 1.04). When censoring for βB discontinuation or treatment switch during follow-up, findings were similar.
"Long-term βB therapy was not associated with improved cardiovascular outcomes during median follow-up of 4.5 years," the authors write. "These findings were consistent across individual secondary end points and across patient subgroups."
Several authors disclosed financial ties to the pharmaceutical industry.
Related Posts
AHA News: Why Are South Asians Dying of Heart Disease? MASALA Looks For Answers.
WEDNESDAY, May 17, 2023 (American Heart Association News) -- Like many people of...
Most Melatonin Gummies Have Inaccurate Labels
WEDNESDAY, April 26, 2023 (HealthDay News) -- Most melatonin gummy products are...
Health Highlights, Nov. 1, 2021
FDA delays decision on Moderna vaccine for teens under 17: The company announced...
El uso diario de internet podría mantener la demencia a raya en los adultos mayores
LUNES, 8 de mayo de 2023 (HealthDay News) -- En un mundo cada vez más consumido...